443 related articles for article (PubMed ID: 19298691)
1. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
Chan E; Hegde A; Chen X
J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance.
Takahashi H; Kashima T; Kimura S; Murata N; Takaba T; Iwade K; Abe T; Tainaka H; Yasumori T; Echizen aH
Drug Metab Dispos; 1999 Oct; 27(10):1179-86. PubMed ID: 10497145
[TBL] [Abstract][Full Text] [Related]
3. Effect of 5-fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats.
Zhou Q; Chan E
Eur J Pharm Sci; 2002 Oct; 17(1-2):73-80. PubMed ID: 12356422
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
Yacobi A; Lai CM; Levy G
J Pharmacol Exp Ther; 1984 Oct; 231(1):80-4. PubMed ID: 6491977
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
Yacobi A; Lai CM; Levy G
J Pharmacol Exp Ther; 1984 Oct; 231(1):72-9. PubMed ID: 6491976
[TBL] [Abstract][Full Text] [Related]
6. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
[TBL] [Abstract][Full Text] [Related]
7. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients.
McAleer SD; Foondun AS; Feely M; Chrystyn H
Chirality; 1997; 9(1):13-6. PubMed ID: 9094197
[TBL] [Abstract][Full Text] [Related]
8. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Van Hecken A; Depré M; Verbesselt R; Wynants K; De Lepeleire I; Arnout J; Wong PH; Freeman A; Holland S; Gertz B; De Schepper PJ
J Clin Pharmacol; 1999 May; 39(5):495-500. PubMed ID: 10234597
[TBL] [Abstract][Full Text] [Related]
9. Effect of ubidecarenone on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
Zhou S; Chan E
Drug Metabol Drug Interact; 2001; 18(2):99-122. PubMed ID: 11460879
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone.
Takahashi H; Sato T; Shimoyama Y; Shioda N; Shimizu T; Kubo S; Tamura N; Tainaka H; Yasumori T; Echizen H
Clin Pharmacol Ther; 1999 Dec; 66(6):569-81. PubMed ID: 10613612
[TBL] [Abstract][Full Text] [Related]
11. Effect of omeprazole on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats.
Zhou Q; Chan E
Eur J Pharm Sci; 2003 Dec; 20(4-5):439-49. PubMed ID: 14659488
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
Modi NB; Kell S; Simon M; Vargas R
J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of effects of terbinafine on single oral dose pharmacokinetics and anticoagulant actions of warfarin in healthy volunteers.
Guerret M; Francheteau P; Hubert M
Pharmacotherapy; 1997; 17(4):767-73. PubMed ID: 9250555
[TBL] [Abstract][Full Text] [Related]
14. Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males.
Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Middle MV
Arzneimittelforschung; 1996 Jan; 46(1):41-6. PubMed ID: 8821516
[TBL] [Abstract][Full Text] [Related]
15. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
Black DJ; Kunze KL; Wienkers LC; Gidal BE; Seaton TL; McDonnell ND; Evans JS; Bauwens JE; Trager WF
Drug Metab Dispos; 1996 Apr; 24(4):422-8. PubMed ID: 8801057
[TBL] [Abstract][Full Text] [Related]
16. Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects.
Lilja JJ; Backman JT; Neuvonen PJ
Br J Clin Pharmacol; 2005 Apr; 59(4):433-9. PubMed ID: 15801938
[TBL] [Abstract][Full Text] [Related]
17. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions.
Wittkowsky AK
Semin Vasc Med; 2003 Aug; 3(3):221-30. PubMed ID: 15199454
[TBL] [Abstract][Full Text] [Related]
18. Treatment of rats with the Pelargonium sidoides extract EPs 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin.
Koch E; Biber A
Phytomedicine; 2007; 14 Suppl 6():40-5. PubMed ID: 17188479
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in pharmacokinetics of oral warfarin in rats.
Zhu X; Shin WG
Biopharm Drug Dispos; 2005 May; 26(4):147-50. PubMed ID: 15776499
[TBL] [Abstract][Full Text] [Related]
20. Effect of plasma protein binding on the anticoagulant action of warfarin in rats.
Yacobi A; Levy G
Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):405-8. PubMed ID: 1197921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
